Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Sweden’s Handicare acquires mobility device developer Prism Medical
Prism Medical said today that mobility and technical aid developer Handicare agreed to acquire it for approximately $62 million.
Swedish Handicare, which supplies technical aids for the elderly and physically disabled, will pay $12.50 for each outstanding share of Prism Medical. Read more
4. Unfazed by Brexit, PureTech launches Sonde voice diagnostics firm
Life sciences incubator PureTech Health, unfazed by the worldwide impact of the U.K.’s vote to leave the European Union, announced its latest venture today: Sonde Health, which aims to use a voice-based technology to diagnose mental and physical ailments.
Based on technology licensed from the Mass. Institute of Technology’s Lincoln Laboratory, Sonde’s device is designed to analyze short vocal samples to screen for conditions based on acoustic changes. Read more
3. Wright Medical wants retrial in Conserve hip implant loss
Wright Medical wants a federal appeals court to overturn the verdict in the 1st bellwether trial over its Conserve metal-on-metal hip implant, arguing that a new trial is warranted because the jury had 2 bites at the apple.
An Atlanta jury last year awarded plaintiff Robyn Christiansen $1 million in compensatory damages and another $10 million in punitive damages. The jury found Nov. 24 that the Conserve device was defective and that Wright failed to adequately warn patients about its risks. Read more
2. Mannkind taps medtech reps after Sanofi deal fails
Mannkind chief commercial officer Michael Castagna is trying to resuscitate the inhaled insulin maker after its co-marketing agreement with Sanofi was cancelled at the beginning of the year due to disappointing sales. He’s fielding a team of about 70 people to sell the company’s Afrezza insulin inhaler, with about 1⁄3 coming from the medical device industry.
“We are looking to build a high energy nimble company that reflects the speed of the medical device industry, articulation of the science from biotech and a relentless focus on helping patients suffering from diabetes,” Castagna told Fortune. Read more
1. Medtronic launches Beacon HF monitoring service
Medtronic said today it launched its Beacon heart failure management service in the U.S., designed to monitor data from cardiac pacing devices to improve early interventions before heart failure events.
The service, which integrates data from the company’s implantable cardioverter defibrillator and cardiac resynchronization therapy devices, will allow patients to engage in daily health checks to both educate patients about conditions and to collect symptoms and biometrics. Read more
The post MassDevice.com +5 | The top 5 medtech stories for June 28, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/293VqOh
Cap comentari:
Publica un comentari a l'entrada